Global Cell Based Assay Market is to reach USD 17.85 billion by 2022.

Posted by rohan on March 13th, 2018

The Global Cell Based Assay Market was worth USD 10.5 billion in 2016 and estimated to be growing at a CAGR of 11.2%, to reach USD 17.85 billion by 2022. Cell based assays are majorly used by biotechnology companies, academic research institutes, contract research organizations government institutions, pharmaceutical companies and others. Cell based assays help to measure cell proliferations, motility, toxicity, production of a measurable product and morphology in diagnostics and drug discovery. Cell based assays facilitate research in the area of stem cells, cancer, immunology and others. On the basis of application, cell based assay market can be classified into drug discovery, predictive toxicology, basic research, ADME studies and others.

View full report @ https://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-2218/

North America, followed by Europe, has the largest market for cell based assays due to increasing drug related research, development activities, rise in adoption of cell based assay platforms and large number of pharmaceutical and biotechnology companies in this region. Asia is expected to show high growth rate in the cell based assays market in next few years due to technological advancement, rise in investments in R&D includes life science research and drug discover outsourcing in the region.

Get free sample report @ https://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-2218/request-sample

Increasing research activities in drug discovery, technological advancement, rise in demand for biological drugs, government expenditure, rising need for toxicity screening in drugs are expected to drive the market for cell based assays. In addition, significant advantages of cell based assay, innovations in technological advanced products and need to reduce costs associated with drug discovery are expected to drive the market for cell based assays. However, lack of skilled professionals, stringent intellectual property rights and high cost of instruments are some of the factors restraining the growth for global cell based assays market.

Inquire before buying @ https://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-2218/inquire 

Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in cell based assays market. In addition, emergence of new technologies such as 3D cell based assays, advanced detection technologies, increasing requirement for toxicity screening and broadened applications of cell based assays are expected to offer new opportunities for global cell based assays market. However, complexity of high throughput screening (HTS) assay, assay optimization and standardization are some of the challenges for the global cell based assays market. Some of the major companies operating in the global cell based assays market are Becton, Dickinson and Company, GE Healthcare, Discoverx, Promega Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Perkinelmer, Inc. and Merck KGaA.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/3204 

Key points covered in the report

Report segments the market on the basis of types, application, products, technology, etc (as applicable)

The report covers geographic segmentation

North America

Europe

Asia

RoW

The report provides the market size and forecast for the different segments and geographies for the period of 2017 to 2022

The report provides company profiles of some of the leading companies operating in the market

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206